Last reviewed · How we verify
ROPIVACAINE HYDROCHLORIDE
At a glance
| Generic name | ROPIVACAINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1996 |
Approved indications
Common side effects
- Hypotension
- Nausea
- Vomiting
- Bradycardia
- Headache
- Paresthesia
- Back pain
- Pain
- Pruritus
- Fever
- Dizziness
- Rigors (Chills)
Serious adverse events
- Fetal bradycardia
- Neonatal jaundice
- Neonatal complication-NOS
- Apgar score low
- Neonatal respiratory disorder
- Neonatal tachypnea
- Neonatal fever
- Fetal tachycardia
- Fetal distress
- Neonatal infection
Key clinical trials
- External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative Pain in Laparoscopic Radical Gastrectomy (NA)
- OMT for Adhesive Capsulitis (PHASE4)
- A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China. (PHASE3)
- Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine (PHASE4)
- Pericapsular Nerve Group (PENG) Block Combined With Lateral Femoral Cutaneous Nerve (LFCN) Block or Wound Infiltration for Postoperative Analgesia in Anterior Approach Total Hip Arthroplasty: A Randomized Controlled Trial (NA)
- Does the Common Practice of Adding Diluted Epinephrine in Tranverse Abdominal Plan Block to Ropivacaine Significantly Decrease the Peak Systemic Resorption of Ropivacaine? (NA)
- Analgesic Effect of the QLB-3 for Patients Undergoing a Total Hip Surgery (NA)
- The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ROPIVACAINE HYDROCHLORIDE CI brief — competitive landscape report
- ROPIVACAINE HYDROCHLORIDE updates RSS · CI watch RSS